F. Kuperstein et al., Biphasic modulation of protein kinase C and enhanced cell toxicity by amyloid beta peptide and anoxia in neuronal cultures, J NEUROCHEM, 76(3), 2001, pp. 758-767
A major feature of Alzheimer's disease is the deposition of the amyloid bet
a peptide (AP) in the brain by mechanisms which remain unclear. One hypothe
sis suggests that oxidative stress and AP aggregation are interrelated proc
esses. Protein kinase C, a major neuronal regulatory protein is activated a
fter oxidative stress and is also altered in the Alzheimer's disease brain.
Therefore, we examined the effects of A beta (1-40) peptide on the protein
kinase C cascade and cell death in primary neuronal cultures following ano
xic conditions. Treatment with A beta (1-40) for 48 h caused a significant
increase in the content and activity of Ca2+-dependent and Ca2+-independent
protein kinase C isoforms. By 72h Various protein kinase C isoforms were d
own-regulated. Following 90 min anoxia and 6 h normoxia, a decrease in prot
ein kinase C isoforms was noticed, independent of A beta (1-40) treatment.
A combination of A beta (1-40) and 30-min anoxia enhanced cytotoxicity as n
oticed by a marked loss in the mitochondrial ability to convert 3-(4,5-dime
thylthiazol-2-yl)-2,5-diphenyl bromide and by enhanced 4',6-diamidino-2-phe
nylindole nuclear staining. Phosphorylation of two downstream protein kinas
e C substrates of apparent molecular mass 80 and 43 kDa, tentatively identi
fied as the mirystoyl alanine-rich C-kinase substrate (MARCKS), were gradua
lly elevated up to 72 h upon incubation with A beta (1-40). Anoxia followed
by 30 min normoxia enhanced MARCKS phosphorylation in the membrane but not
in the cytosolic fraction. In the presence of A beta (1-40), phosphorylati
on of MARCKS was reduced. After 6h normoxia, MARCKS phosphorylability was d
iminished possibly because of protein kinase C down-regulation. The data su
ggest that a biphasic modulation of protein kinase C and MARCKS by A beta (
1-40) combined with anoxic stress may play a role in Alzheimer's disease pa
thology.(1).